Skip to main content
VIYASH SCIENTIFIC LIMITED logo

VIYASH SCIENTIFIC LIMITED — Investor Relations & Filings

Ticker · VIYASH ISIN · INE807F01027 LEI · 335800SXM7D3VSHF2X07 BSE.NS Manufacturing
Open in API
Filings indexed 1,424 across all filing types
Latest filing 2025-01-10 Regulatory Filings
Country IN India
Listing BSE.NS VIYASH

About VIYASH SCIENTIFIC LIMITED

https://www.viyash.com

Viyash Scientific Limited is an integrated pharmaceutical platform specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs), advanced intermediates, and finished dosage forms. The organization operates a network of manufacturing facilities supported by robust research and development capabilities, focusing on complex chemistry and niche therapeutic segments. Its core business activities encompass the entire pharmaceutical value chain, from process development and scale-up to commercial-scale production. The company provides integrated solutions to global partners, leveraging its technical expertise in chemical synthesis and commitment to international quality standards. By maintaining a focus on operational excellence and innovation, the company serves as a strategic partner in the global healthcare supply chain, delivering high-quality medicinal components and formulations.

Recent filings

Filing Released Lang Actions
Certificate in terms of Regulation 74(5) of the SEBI (Depositories and Participants) Regulation , 2018.
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming details of securities dematerialized/rematerialized for the quarter ended December 31, 2024. It is addressed to stock exchanges and signed by the company secretary and the registrar. The document is short (2382 characters) and serves as a compliance certificate rather than a financial report or detailed filing. It does not contain financial statements, management discussion, or audit information. It is a regulatory compliance certificate related to shareholding and securities dematerialization. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2025-01-10 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notice regarding the closure of the trading window for insiders ahead of the announcement of unaudited financial results for the quarter and nine months ending December 31, 2024. It references the upcoming financial results but does not contain any financial data or the results themselves. The document is short (2081 characters) and serves as an announcement related to compliance with insider trading regulations. It is not a financial report, earnings release, or detailed presentation. Therefore, it fits best as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2024-12-31 English
Notice of closure of trading window
Regulatory Filings Classification · 95% confidence The document is a notice regarding the closure of the trading window for insiders ahead of the announcement of unaudited financial results for the quarter and nine months ending December 31, 2024. It references the upcoming declaration of financial results but does not contain any financial data or the results themselves. The document is short (2081 characters) and serves as an announcement related to regulatory compliance and insider trading restrictions. Therefore, it is not a financial report or earnings release but a regulatory announcement. Given the nature and length, it fits best under Regulatory Filings (RNS).
2024-12-31 English
Copy of Newspaper Publication
Regulatory Filings
2024-12-27 English
Newspaper intimation regarding transfer of Equity Shares to IEPF Authority.
Regulatory Filings Classification · 72% confidence The document is a corporate notice to the BSE and NSE under SEBI Listing Obligations and Disclosure Requirements announcing the publication of newspaper advertisements (IEPF transfer notice and basis of allotment). It does not contain financial statements or earnings data, nor is it the report itself (just a compliance announcement and ad copies). This is a general regulatory compliance announcement, which falls under Regulatory Filings (RNS).
2024-12-27 English
Appointment
Board/Management Information Classification · 100% confidence The document is an official communication addressed to stock exchanges regarding changes in the company's board and key managerial personnel. It details the appointment of a new independent director, the cessation of the company secretary, and the appointment of a new company secretary. The document references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, specifically Regulation 30, which pertains to disclosures about changes in directors and key managerial personnel. There are no financial statements, earnings data, or other report content. The document is a formal announcement of management changes rather than a report or financial filing. Therefore, it fits the category of Board/Management Information (MANG). The document length (7694 characters) supports it being a detailed announcement rather than a brief notice or a report publication announcement.
2024-12-16 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.